HUNT DOUGLAS M 4

What Happened
Douglas M. Hunt, Senior Vice President of Regulatory Affairs at Puma Biotechnology (PBYI), disposed of 8,460 shares on July 6, 2026. The shares were sold at $8.26 per share for total proceeds of $69,905. This was a sale (not a purchase) and was executed under a pre-arranged 10b5-1(c) sell-to-cover program.

Key Details

• Transaction date and price: 2026-07-06 — 8,460 shares sold at $8.26 each.
• Total proceeds: $69,905.
• Shares owned after transaction: Not specified in this Form 4 filing.
• Plan/footnote: Sale executed under a 10b5-1(c) plan adopted on 12-14-2020 (sell-to-cover).
• Filing timeliness: Report filed 2026-07-08 for a 2026-07-06 transaction (filed within the standard 2-business-day window).

Context
Sales made under 10b5-1 plans are pre-arranged and often routine (e.g., for tax obligations or diversification); they do not necessarily reflect a change in the insider’s view of the company. This transaction was a straightforward open-market sale (code S) by an officer, and the filing provides no additional indication of the insider’s ongoing ownership level or intent.